Tiemeier G L, Brown J M, Pratap S E, McCarthy C, Kastrenopoulou A, Bradley K, Wilson S, Orosz Z, Gibbons C L M H, Oppermann U, Athanasou N A
1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, Oxford, OX3 7HE UK.
2Sarcoma Service, Nuffield Orthopaedic Centre, Oxford, UK.
Clin Sarcoma Res. 2018 Feb 9;8:2. doi: 10.1186/s13569-018-0089-7. eCollection 2018.
Liposarcoma is an extremely rare primary bone sarcoma.
We report a case of primary pleomorphic liposarcoma that arose in an 18 year old male in the metaphysis of the left tibia. Plain radiographs showed a partly sclerotic lesion and MR imaging a heterogeneous tumour predominantly isointense on T1- and high-signal on T2-weighted sequences with focal areas of increased T1 signal that suppressed with fat saturation. PET/CT showed marked FDG uptake (SUV = 17.1) in the primary tumour as well as a metastasis in the right distal femur and multiple small pulmonary metastases. Histologically, the tumour was a pleomorphic liposarcoma containing large tumour cells with vacuolated cytoplasm and hyperchromatic pleomorphic nuclei as well as numerous lipoblasts and scattered brown fat-like cells. Tumour cells strongly expressed FABP4/aP2, a marker of adipocyte differentiation, and UCP1, a marker of brown fat, but not S100. The case was treated with neoadjuvant MAP chemotherapy, resulting in extensive (> 95%) necrosis in the primary tumour and almost complete resolution of the femoral and pulmonary metastases.
Pleomorphic liposarcoma can present as a sclerotic primary malignant bone tumour; markers of adipose differentiation are useful in histological diagnosis and neoadjuvant MAP chemotherapy results in significant tumor necrosis.
脂肪肉瘤是一种极其罕见的原发性骨肉瘤。
我们报告一例原发性多形性脂肪肉瘤,发生于一名18岁男性的左胫骨干骺端。X线平片显示部分硬化性病变,磁共振成像显示肿瘤不均匀,在T1加权序列上主要呈等信号,在T2加权序列上呈高信号,T1信号有局灶性增高,脂肪抑制序列上信号被抑制。PET/CT显示原发肿瘤有明显的氟代脱氧葡萄糖摄取(SUV = 17.1),右股骨远端有转移灶,还有多个小的肺转移灶。组织学上,肿瘤为多形性脂肪肉瘤,含有大的肿瘤细胞,胞质有空泡,核呈多形性深染,还有大量脂肪母细胞和散在的棕色脂肪样细胞。肿瘤细胞强烈表达脂肪细胞分化标志物FABP4/aP2和棕色脂肪标志物UCP1,但不表达S100。该病例接受了新辅助MAP化疗,导致原发肿瘤广泛(> 95%)坏死,股骨和肺转移灶几乎完全消退。
多形性脂肪肉瘤可表现为硬化性原发性恶性骨肿瘤;脂肪分化标志物有助于组织学诊断,新辅助MAP化疗可导致显著的肿瘤坏死。